National Health Care (Russia), volume 5, issue 4, pages 38-50

Regulatory legal regulation of the organization and financial provision of supportive therapy for oncological diseases and directions for its optimization

Publication typeJournal Article
Publication date2025-01-21
SJR
CiteScore0.7
Impact factor
ISSN2713069X, 27130703
Abstract

The potential benefits of supportive care offer patients more than many “palliative” methods of anti-tumor treatment. It should be regarded as a necessary part of comprehensive disease therapy rather than just an additional service. However, the imperfection of regulatory and organizational issues, including financial support, limits patients’ access to supportive therapy.

Aim. To analyze regulatory legal documents governing the organization and financial provision of supportive therapy for oncological diseases and identify areas for optimization.

Materials and methods. Content analysis and comparative legal analysis. The content analysis method was applied to 26 directly regulating various organizational aspects of medical care, including oncological diseases from 2012 to the present. In regulatory legal acts, the issues of organization and financing of supportive therapy for oncological diseases were specifically analyzed in terms of how well this area of medical care is regulated.

Results. The current fundamental regulatory legal acts governing the organization and financial provision of supportive therapy for oncological diseases and controlling the quality of the provided medical care contain almost no clear provisions that specify practical issues related to supportive therapy.

Conclusion. The absence of an officially established definition of “supportive therapy” within the Russian healthcare system and the lack of clear distinctions between the terms “medical rehabilitation” and “palliative care” lead to misunderstanding about the importance of this area in comprehensive oncological therapy. This results in uncertainty in organizational and financial matters. To optimize regulatory oversight, ‘supportive therapy’ should become an integral component of modern oncological disease management, implying both interdisciplinary cooperation and a transparent financial system, the adequacy of which will depend on what is included in this concept.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Zheleznyakova I. Regulatory legal regulation of the organization and financial provision of supportive therapy for oncological diseases and directions for its optimization // National Health Care (Russia). 2025. Vol. 5. No. 4. pp. 38-50.
GOST all authors (up to 50) Copy
Zheleznyakova I. Regulatory legal regulation of the organization and financial provision of supportive therapy for oncological diseases and directions for its optimization // National Health Care (Russia). 2025. Vol. 5. No. 4. pp. 38-50.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.47093/2713-069x.2024.5.4.38-50
UR - https://www.natszdrav.ru/jour/article/view/411
TI - Regulatory legal regulation of the organization and financial provision of supportive therapy for oncological diseases and directions for its optimization
T2 - National Health Care (Russia)
AU - Zheleznyakova, I.A.
PY - 2025
DA - 2025/01/21
PB - Sechenov University
SP - 38-50
IS - 4
VL - 5
SN - 2713-069X
SN - 2713-0703
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Zheleznyakova,
author = {I.A. Zheleznyakova},
title = {Regulatory legal regulation of the organization and financial provision of supportive therapy for oncological diseases and directions for its optimization},
journal = {National Health Care (Russia)},
year = {2025},
volume = {5},
publisher = {Sechenov University},
month = {jan},
url = {https://www.natszdrav.ru/jour/article/view/411},
number = {4},
pages = {38--50},
doi = {10.47093/2713-069x.2024.5.4.38-50}
}
MLA
Cite this
MLA Copy
Zheleznyakova, I.A.. “Regulatory legal regulation of the organization and financial provision of supportive therapy for oncological diseases and directions for its optimization.” National Health Care (Russia), vol. 5, no. 4, Jan. 2025, pp. 38-50. https://www.natszdrav.ru/jour/article/view/411.
Found error?